NDC 51224-153-12 - Aluminum Acetate Astringent
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 51224-153
- Requested NDC
- 51224-153-12
- Package NDCs from labels
- 51224-153-99, 51224-153-12, 51224-153-24
- Manufacturer
- TAGI Pharma Incorporated
- Effective date
- 2018-11-20
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Aluminum Acetate Astringent - TAGI Pharma Incorporated | TAGI Pharma Incorporated | 2018-11-20 | HUMAN OTC DRUG LABEL |
| National Council for Prescription Drug Programs indexing - billing unit | National Council for Prescription Drug Programs | 2012-07-24 | Indexing - Billing Unit |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 51224-153-12 | EA - Each | 51224-153 | 5d44d708-f3d0-4fce-a247-43c5e59de299 | 1 | 2012-07-24 |
| 51224-153-24 | EA - Each | 51224-153 | ddadcdbf-7122-439a-a34f-4b489cf5f0f1 | 1 | 2012-07-24 |
| 51224-153-99 | EA - Each | 51224-153 | cac4fea4-7db4-455e-b348-f2ee4916b3a1 | 1 | 2012-07-24 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| Aluminum sulfate | ACTIVE INGREDIENT | 34S289N54E | ALUMINUM ACETATE ASTRINGENT (CALCIUM ACETATE AND ALUMINUM SULFATE) POWDER, FOR SOLUTION [TAGI PHARMA INCORPORATED] | 1 | |
| Calcium Acetate | ACTIVE INGREDIENT | Y882YXF34X | ALUMINUM ACETATE ASTRINGENT (CALCIUM ACETATE AND ALUMINUM SULFATE) POWDER, FOR SOLUTION [TAGI PHARMA INCORPORATED] | 1 | |
| Aluminum Cation | ACTIVE MOIETY | 3XHB1D032B | ALUMINUM ACETATE ASTRINGENT (CALCIUM ACETATE AND ALUMINUM SULFATE) POWDER, FOR SOLUTION [TAGI PHARMA INCORPORATED] | 1 | |
| Calcium Cation | ACTIVE MOIETY | 2M83C4R6ZB | ALUMINUM ACETATE ASTRINGENT (CALCIUM ACETATE AND ALUMINUM SULFATE) POWDER, FOR SOLUTION [TAGI PHARMA INCORPORATED] | 1 | |
| icodextrin | INACTIVE INGREDIENT | 2NX48Z0A9G | ALUMINUM ACETATE ASTRINGENT (CALCIUM ACETATE AND ALUMINUM SULFATE) POWDER, FOR SOLUTION [TAGI PHARMA INCORPORATED] | 1 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Calcium Acetate | CALCIUM ACETATE | American Health Packaging | 2072d9f4-abb1-4699-bde5-6041dd79cad5 | 2026-09-04 | Warnings, Adverse reactions | Y882YXF34X |
| calcium acetate | CALCIUM ACETATE | REMEDYREPACK INC. | 89a2ee04-1024-4a81-ba0d-a6655d529827 | 2026-09-03 | Warnings, Adverse reactions | Y882YXF34X |
| Calcium Acetate | CALCIUM ACETATE | AvPAK | 52e35dd6-db95-98e6-e063-6294a90ab801 | 2026-05-28 | Warnings, Adverse reactions | Y882YXF34X |
| Calcium Acetate | CALCIUM ACETATE | Rising Pharma Holdings, Inc. | ce650ba5-fb42-e444-e053-2a95a90a075a | 2026-05-15 | Warnings, Adverse reactions | Y882YXF34X |
| Calcium Acetate | CALCIUM ACETATE | NCS HealthCare of KY, LLC dba Vangard Labs | 7177829c-bd89-485c-b5e3-15e457e969c5 | 2026-04-17 | Warnings, Adverse reactions | Y882YXF34X |
| Calcium Acetate | CALCIUM ACETATE | Cardinal Health 107, LLC | a23b6070-eb4b-48e3-b563-8232206a6be4 | 2026-04-15 | Warnings, Adverse reactions | Y882YXF34X |
| Calcium Acetate | CALCIUM ACETATE | Major Pharmaceuticals | 9a731cdf-6488-44ca-b97f-512a0e9deab1 | 2026-03-17 | Warnings, Adverse reactions | Y882YXF34X |
| Calcium Acetate | CALCIUM ACETATE | Westminster Pharmaceuticals, LLC | 1195f5d5-db91-4b9e-86ad-be340b43d690 | 2026-02-24 | Warnings, Adverse reactions | Y882YXF34X |
| THY-Plex | THYROID SUPPORT | Vitality Works, Inc. | deea70d1-5175-4c7e-ae69-dd48ff212f08 | 2025-12-17 | Warnings | Y882YXF34X |
| calcium acetate | CALCIUM ACETATE | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | d48c66a9-26fe-4e1a-a68a-88afe83fb51d | 2025-07-01 | Warnings, Adverse reactions | Y882YXF34X |
| EXTRANEAL | ICODEXTRIN, SODIUM CHLORIDE, SODIUM LACTATE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE | Vantive US Healthcare LLC | d5b85158-b0d6-4855-9d07-8d1b3ad9ab71 | 2025-06-30 | Warnings, Adverse reactions | 2NX48Z0A9G |
| calcium acetate | CALCIUM ACETATE | AvKARE | 35a6f515-dfe7-031c-e063-6294a90a5e95 | 2025-06-04 | Warnings, Adverse reactions | Y882YXF34X |
| Calcium Acetate | CALCIUM ACETATE | Proficient Rx LP | 80c15366-9420-41c2-8817-b9c39ddfcec1 | 2025-06-01 | Warnings, Adverse reactions | Y882YXF34X |
| EXTRANEAL | ICODEXTRIN, SODIUM CHLORIDE, SODIUM LACTATE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE | Vantive US Healthcare LLC | 5bf31b49-24c8-4021-98da-33a151f2fcbe | 2025-05-08 | 2NX48Z0A9G | |
| EXTRANEAL | ICODEXTRIN, SODIUM CHLORIDE, SODIUM LACTATE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE | Vantive US Healthcare LLC | e18bacfe-af60-49dc-bd30-cb3c29fa16db | 2025-05-07 | 2NX48Z0A9G | |
| EXTRANEAL | ICODEXTRIN, SODIUM CHLORIDE, SODIUM LACTATE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE | Vantive US Healthcare LLC | 2b327b13-a0e9-4b2c-9875-4470998e2e30 | 2025-05-07 | 2NX48Z0A9G | |
| Calcium Acetate | CALCIUM ACETATE | Hikma Pharmaceuticals USA Inc. | 85fd41f8-2823-44ca-a15e-f1f2e5d0ff94 | 2025-04-17 | Warnings, Adverse reactions | Y882YXF34X |
| Aluminium sulphuricum | ALUMINIUM SULPHURICUM | Hahnemann Laboratories, Inc. | a474ba15-34a5-f07e-e053-2995a90a61ca | 2025-01-09 | 34S289N54E | |
| Calcium Acetate | CALCIUM ACETATE | Chartwell RX LLC | 9584350a-b6ad-45ae-b1c5-c8ca8f471c03 | 2024-10-14 | Warnings, Adverse reactions | Y882YXF34X |
| B08 MUCOUS MEMBRANES | BALSAMUM PERUVIANUM, BORAX, BRYONIA, CALCAREA ACETICA, COCCUS CACTI, ECHINACEA ANGUSTIFOLIA, ECHINACEA PURPUREA, EUCALYPTUS GLOBULUS, EUPHORBIUM OFFICINARUM, EUPHRASIA OFFICINALIS, HISTAMINUM HYDROCHLORICUM, IPECACUANHA, KALI BICHROMICUM, LUFFA OPERCULATA, MERCURIUS CYANATUS, MERCURIUS DULCIS, MERCURIUS SULPHURATUS RUBER, NATRUM ARSENICICUM, PANCREATINUM, SAMBUCUS NIGRA, SANGUINARINUM NITRICUM, SAPONARIA OFFICINALIS | Apex Energetics Inc. | bf8e9d3a-b633-8cf2-e053-2995a90a0930 | 2024-01-08 | Warnings | Y882YXF34X |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.